Your browser doesn't support javascript.
loading
Acute infusion effects in relapsing multiple sclerosis patients receiving alemtuzumab under a modified prophylaxis regimen.
Leckey, Richard; Borsellino, Liborio; Rawlings, Andreea M; Ashkenas, John; Suri, Amit.
Affiliation
  • Leckey R; Maritime Neurology, 349 Herring Cove Road, Herring Cove, Halifax, NS B3R 1V9, Canada; Division of Neurology, Dalhousie University, Halifax, NS, Canada. Electronic address: rleckey5@gmail.com.
  • Borsellino L; Sanofi Canada, Mississauga, ON, Canada.
  • Rawlings AM; Sanofi, Cambridge, MA, USA.
  • Ashkenas J; imc North America, Toronto, ON, Canada.
  • Suri A; Sanofi Canada, Mississauga, ON, Canada.
Mult Scler Relat Disord ; 66: 104030, 2022 Oct.
Article in En | MEDLINE | ID: mdl-35870368
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Mult Scler Relat Disord Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Mult Scler Relat Disord Year: 2022 Document type: Article Country of publication: